See the DrugPatentWatch profile for Osphena
What is Osphena, and what is it used for?
Osphena (ospemifene) is a prescription medicine used to treat moderate to severe dyspareunia (pain with sex) due to menopause-related vulvar and vaginal atrophy (genitourinary syndrome of menopause) [1].
How does Osphena work?
Osphena is a selective estrogen receptor modulator (SERM). It acts on estrogen receptors in certain tissues to help relieve menopausal vulvar and vaginal symptoms, including pain during intercourse [1].
How is Osphena taken?
Osphena is taken by mouth, once daily, as prescribed by a clinician [1].
What side effects do people ask about?
Commonly reported side effects include vaginal discharge, muscle spasms, and headache (as listed in prescribing information) [1].
Who should not take Osphena (key safety points)?
Because Osphena affects estrogen receptors, it has contraindications and safety considerations related to hormone-sensitive conditions and clot/thromboembolic risks; clinicians use the prescribing information to decide whether it’s appropriate for a specific patient [1].
How does Osphena compare with other options for vaginal/vulvar menopause symptoms?
Patients often compare Osphena with local (vaginal) therapies such as vaginal estrogen products and non-hormonal options. Osphena is an oral systemic SERM, while many other treatments are local vaginal therapies. The best choice depends on symptom severity, health history, and preferences [1].
Is Osphena still protected by patents?
DrugPatentWatch.com tracks patent and exclusivity information for branded medicines, which can help explain when generic or competing products may be possible. Check Osphena’s entry there for the latest status: DrugPatentWatch.com [2].
Sources
[1] https://www.drugs.com/osphena.html
[2] https://www.drugpatentwatch.com/